NuEnergy Gas (ASX:NGY) Faces $1.1 Million Claim From Former Director Ian Wang

Sonal Goyal

11 September 2026 01:17 PM AEST

NuEnergy Gas (ASX:NGY) Faces $1.1 Million Claim From Former Director Ian Wang

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

NuEnergy Gas Limited (ASX:NGY) received a Demand from former director Dr Ian Wang claiming $1,106,317.46, including interest, for unpaid remuneration.
The claim relates to Dr Wang's tenure as Chief Executive Officer and Non-Executive Director between August 2018 and July 2026.
The company acknowledges unpaid remuneration of $195,000, which it states is not presently due and is already provided for in its financial statements.
NGY shares fell 6.06% to A$0.031 on the day the announcement was released.

Details of the Claim

NuEnergy Gas Limited (ASX:NGY) advised the market that on 9 September 2026 it received a demand for payment of outstanding remuneration and employment entitlements from Dr Ian Wang, a former director of the company. Under the demand, Dr Wang is claiming a total of $1,106,317.46, including interest, in respect of unpaid remuneration accrued during his tenure as Chief Executive Officer and Non-Executive Director, spanning August 2018 to July 2026.

The company stated that it has a written agreement with Dr Wang covering the deferral and Waiver of remuneration, which has been disclosed in its Annual Reports from 2020 onwards. The company referenced disclosure contained in the 2025 Remuneration Report and the 2025 Annual Report announced to the ASX on 26 September 2025.

Company's Position

On the basis of this written agreement, NuEnergy Gas acknowledges unpaid remuneration owed to Dr Wang totalling $195,000, which it states is not presently due and payable. This amount has already been provided for in the company's financial statements.

The company said it is currently assessing the claim from Dr Wang but considers that it is not liable to him to the extent set out in the demand. No further detail was provided in the announcement regarding the specific basis on which the company disputes the larger claimed amount, and the matter remains under review.

Conclusion

NuEnergy Gas has disclosed a remuneration dispute with a former director covering an eight-year tenure, with the amount claimed by Dr Wang significantly exceeding the sum the company currently acknowledges as owing. With $195,000 already provided for in its accounts and the remainder of the claim disputed, the company has indicated the matter is still being assessed, and shareholders will need to monitor further disclosures as the dispute progresses.

FAQs

Q: Who has made a claim against NuEnergy Gas?

A: Dr Ian Wang, a former director and Chief Executive Officer of the company, has made a claim for outstanding remuneration and employment entitlements.

Q: How much is Dr Wang claiming?

A: Dr Wang is claiming a total of $1,106,317.46, including interest, covering his tenure from August 2018 to July 2026.

Q: How much does NuEnergy Gas acknowledge owing?

A: The company acknowledges $195,000 in unpaid remuneration, which it states is not presently due and is already provided for in its financial statements.

Q: Does the company accept the full amount of the claim?

A: No, the company states it is assessing the claim and considers it is not liable to Dr Wang to the extent referred to in the demand.

Q: How did NGY shares react to the announcement?

A: NGY shares declined 6.06% to A$0.031 on the day the claim was disclosed.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.